Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology

European Journal of Preventive Cardiology
Martin WagnerEUROASPIRE IV investigators

Abstract

Aims Chronic kidney disease (CKD) is associated with the development and progression of coronary heart disease (CHD), in addition to classic cardiovascular risk factors. We analysed the prevalence of CKD in CHD patients from 24 European countries in the ambulatory setting and in a preceding hospital stay for CHD (index). Methods and results A total of 7998 EUROASPIRE IV participants (median 65 years of age, 76% male) attended a study visit 6-36 months after the index hospitalisation. CKD was classified according to stages of estimated glomerular filtration rate (eGFR) and albuminuria (urinary albumin/creatinine ratio). In stable CHD conditions (study visit), 17.3% had CKD (eGFR <60 mL/min/1.73 m2) with variation among participating countries (range 13.1-26.4%). A further 12% presented with preserved eGFR but significant albuminuria. During the hospital stay due to a coronary event, impaired kidney function was observed in 17.6% (range 7.5-38.2%). Risk factors for impaired kidney function included older age, female gender, classic cardiovascular (CV) risk factors, details of CHD history and congestive heart failure (multivariate regression). Of all patients, 38.9% had declined, 31.3% were stable and 29.8% had improved kidney fun...Continue Reading

References

Jun 10, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G M ChertowB J McNeil
Sep 29, 2000·The American Journal of Cardiology·R R AzarD J Cohen
Sep 24, 2004·The New England Journal of Medicine·Nagesh S AnavekarMarc A Pfeffer
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Shigehiko UchinoUNKNOWN Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
Jan 18, 2006·BMJ : British Medical Journal·Caroline A DalyUNKNOWN Euro Heart Survey Investigators
Feb 8, 2006·Circulation·Hans L HillegeDirk J van Veldhuisen
May 23, 2006·BMJ : British Medical Journal·Marcello TonelliUNKNOWN Cholesterol and Recurrent Events (CARE) Trial Investigators
Nov 7, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jula K InrigLynda A Szczech
Jan 8, 2008·Journal of the American Society of Nephrology : JASN·Ron T van DomburgDon Poldermans
Apr 12, 2008·Journal of the American College of Cardiology·Peter A McCullough
Apr 15, 2008·BMC Public Health·Qiu-Li Zhang, Dietrich Rothenbacher
Jul 30, 2008·American Journal of Nephrology·William M McClellanDavid G Warnock
Oct 13, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Lisa M MielniczukRobert M Califf
Dec 29, 2009·European Heart Journal·Claudio RoncoUNKNOWN Acute Dialysis Quality Initiative (ADQI) consensus group
Jun 16, 2010·Circulation·Jeremy S Bock, Stephen S Gottlieb
Jan 19, 2011·Circulation·Matthew T JamesUNKNOWN Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators
Mar 2, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Samer A M NashefUlf Lockowandt
Feb 18, 2015·European Journal of Preventive Cardiology·Kornelia KotsevaUNKNOWN on behalf of the EUROASPIRE Investigators
Dec 25, 2015·Journal of the American Society of Nephrology : JASN·Katharina BrückUNKNOWN European CKD Burden Consortium
May 14, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Babak BohlouliScott Klarenbach

❮ Previous
Next ❯

Citations

Jul 1, 2017·European Journal of Preventive Cardiology·Massimo F Piepoli
Jun 22, 2019·European Journal of Preventive Cardiology·Massimo F Piepoli
Jul 26, 2019·Expert Opinion on Pharmacotherapy·Niki KatsikiMaciej Banach
Feb 26, 2020·Current Medical Research and Opinion·Panagiotis AnagnostisDimitri P Mikhailidis
Mar 12, 2021·European Journal of Preventive Cardiology·Chou-Pin KuoDer-Cherng Tarng
Apr 7, 2021·American Journal of Hypertension·Tianlin HeJoachim Beige

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass
coronary

Software Mentioned

EUROSCORE
SAS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

JAMA : the Journal of the American Medical Association
Stein I HallanChronic Kidney Disease Prognosis Consortium
Annals of Internal Medicine
Catherine M ClaseONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Rando
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Luca De NicolaANMCO-SIN Research Group
© 2022 Meta ULC. All rights reserved